Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Psoriasis × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 10 Carcinoma, Non-Small-Cell Lung 7 Recurrence 6 Colorectal Neoplasms 6 Neoplasm Metastasis 4 Colonic Neoplasms 4 Rectal Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Sezary Syndrome 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Meningeal Carcinomatosis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lung Neoplasms 2 Infertility 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Anovulation 2 Adenoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thyroid Diseases 1 Squamous Intraepithelial Lesions 1 Smoking 1 Psoriasis 1 Precancerous Conditions 1 Polyps 1

Interventions

tofacitinib 6 Etanercept 6 Adalimumab 4 Methotrexate 3 secukinumab 2 sotrastaurin 1 purine 1 fumaric acid 1 calcipotriene 1 baricitinib 1 apremilast 1 Vitamin D 1 Vaccines 1 Sulfasalazine 1 Saline Solution 1 Mesalamine 1 Mercaptopurine 1 Infliximab 1 Herpes Zoster Vaccine 1 Folic Acid 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Eating 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Biopsy 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00932113 2017-08-31

MOA

Tufts Medical Center

Phase 4 Completed

33 enrolled 11 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡